Kiribati

Kiribati

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
7.49 (6.13 - 8.88) 2019 Modelled IHME
7.59 (5.99 - 9.04) 2018 Modelled IHME
7.77 (5.79 - 9.44) 2017 Modelled IHME
8.18 (6.11 - 9.76) 2016 Modelled IHME
8.48 (6.40 - 10.33) 2015 Modelled IHME
8.48 (6.42 - 10.23) 2014 Modelled IHME
8.47 (6.42 - 10.18) 2013 Modelled IHME
8.46 (6.35 - 10.16) 2012 Modelled IHME
8.45 (6.31 - 10.23) 2011 Modelled IHME
8.45 (6.26 - 10.33) 2010 Modelled IHME
8.55 (6.31 - 10.39) 2009 Modelled IHME
8.78 (6.50 - 10.64) 2008 Modelled IHME
9.04 (6.69 - 10.94) 2007 Modelled IHME
9.27 (6.86 - 11.22) 2006 Modelled IHME
9.36 (6.96 - 11.43) 2005 Modelled IHME
9.34 (7.01 - 11.33) 2004 Modelled IHME
9.29 (7.04 - 11.25) 2003 Modelled IHME
9.23 (7.10 - 11.15) 2002 Modelled IHME
9.18 (7.11 - 11.07) 2001 Modelled IHME
9.15 (7.08 - 11.08) 2000 Modelled IHME
9.27 (7.11 - 11.21) 1999 Modelled IHME
9.54 (7.11 - 11.62) 1998 Modelled IHME
9.87 (7.10 - 12.14) 1997 Modelled IHME
10.15 (7.09 - 12.58) 1996 Modelled IHME
10.29 (7.09 - 12.81) 1995 Modelled IHME
10.31 (7.10 - 12.74) 1994 Modelled IHME
10.34 (7.17 - 12.67) 1993 Modelled IHME
10.36 (7.23 - 12.65) 1992 Modelled IHME
10.38 (7.33 - 12.71) 1991 Modelled IHME
10.39 (7.41 - 12.76) 1990 Modelled IHME
15.2 (12.28 - 18.44) 2015 Modelled WHO
9.1 (6.20 - 10.50) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
2.75 (1.78 - 3.64) 2019 Modelled IHME
2.8 (1.64 - 3.65) 2018 Modelled IHME
2.87 (1.59 - 3.81) 2017 Modelled IHME
3 (1.61 - 4.02) 2016 Modelled IHME
3.09 (1.65 - 4.24) 2015 Modelled IHME
3.04 (1.62 - 4.15) 2014 Modelled IHME
2.92 (1.55 - 3.96) 2013 Modelled IHME
2.78 (1.48 - 3.77) 2012 Modelled IHME
2.66 (1.39 - 3.62) 2011 Modelled IHME
2.61 (1.36 - 3.57) 2010 Modelled IHME
2.71 (1.42 - 3.70) 2009 Modelled IHME
2.94 (1.55 - 3.98) 2008 Modelled IHME
3.21 (1.69 - 4.33) 2007 Modelled IHME
3.44 (1.81 - 4.63) 2006 Modelled IHME
3.54 (1.84 - 4.81) 2005 Modelled IHME
3.44 (1.82 - 4.60) 2004 Modelled IHME
3.21 (1.74 - 4.31) 2003 Modelled IHME
2.94 (1.64 - 3.92) 2002 Modelled IHME
2.71 (1.57 - 3.63) 2001 Modelled IHME
2.61 (1.54 - 3.53) 2000 Modelled IHME
2.77 (1.58 - 3.74) 1999 Modelled IHME
3.17 (1.69 - 4.32) 1998 Modelled IHME
3.7 (1.84 - 5.08) 1997 Modelled IHME
4.25 (2.03 - 5.87) 1996 Modelled IHME
4.7 (2.22 - 6.58) 1995 Modelled IHME
5.06 (2.41 - 6.95) 1994 Modelled IHME
5.41 (2.62 - 7.31) 1993 Modelled IHME
5.74 (2.83 - 7.73) 1992 Modelled IHME
6.06 (3.06 - 8.26) 1991 Modelled IHME
6.35 (3.31 - 8.75) 1990 Modelled IHME
3.65 (2.51 - 5.18) 2015 Modelled WHO
3.3 (2.40 - 4.60) 2014 Survey/reported WHO WPRO, Woodring J et al, 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
7,697 (5,491 - 9,451) 1990 Modelled IHME
7,823 (5,522 - 9,579) 1991 Modelled IHME
7,928 (5,533 - 9,680) 1992 Modelled IHME
8,021 (5,558 - 9,828) 1993 Modelled IHME
8,111 (5,581 - 10,017) 1994 Modelled IHME
8,208 (5,654 - 10,218) 1995 Modelled IHME
8,229 (5,745 - 10,194) 1996 Modelled IHME
8,137 (5,854 - 10,008) 1997 Modelled IHME
8,007 (5,968 - 9,755) 1998 Modelled IHME
7,923 (6,081 - 9,581) 1999 Modelled IHME
7,973 (6,166 - 9,655) 2000 Modelled IHME
8,144 (6,310 - 9,827) 2001 Modelled IHME
8,348 (6,420 - 10,083) 2002 Modelled IHME
8,570 (6,496 - 10,379) 2003 Modelled IHME
8,790 (6,593 - 10,660) 2004 Modelled IHME
8,987 (6,678 - 10,965) 2005 Modelled IHME
9,076 (6,718 - 10,987) 2006 Modelled IHME
9,035 (6,684 - 10,929) 2007 Modelled IHME
8,938 (6,624 - 10,837) 2008 Modelled IHME
8,868 (6,549 - 10,774) 2009 Modelled IHME
8,914 (6,598 - 10,895) 2010 Modelled IHME
9,049 (6,754 - 10,954) 2011 Modelled IHME
9,185 (6,895 - 11,033) 2012 Modelled IHME
9,320 (7,058 - 11,204) 2013 Modelled IHME
9,448 (7,152 - 11,403) 2014 Modelled IHME
9,564 (7,220 - 11,659) 2015 Modelled IHME
9,342 (6,982 - 11,154) 2016 Modelled IHME
8,995 (6,695 - 10,926) 2017 Modelled IHME
8,889 (7,013 - 10,596) 2018 Modelled IHME
8,882 (7,274 - 10,528) 2019 Modelled IHME
10,000 (7,000 - 12,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
13.5 (8.37 - 20.20) 2019 Modelled IHME
13.6 (8.42 - 20.20) 2018 Modelled IHME
13.7 (8.53 - 20.20) 2017 Modelled IHME
13.8 (8.58 - 20.60) 2016 Modelled IHME
13.9 (8.67 - 20.70) 2015 Modelled IHME
13.9 (8.76 - 20.70) 2014 Modelled IHME
13.9 (8.74 - 20.70) 2013 Modelled IHME
13.8 (8.83 - 20.30) 2012 Modelled IHME
13.7 (8.84 - 20.20) 2011 Modelled IHME
13.8 (8.93 - 20) 2010 Modelled IHME
13.8 (8.99 - 20) 2009 Modelled IHME
14 (9.15 - 20.30) 2008 Modelled IHME
14.2 (9.25 - 20.50) 2007 Modelled IHME
14.4 (9.41 - 20.70) 2006 Modelled IHME
14.7 (9.62 - 21.10) 2005 Modelled IHME
15.1 (9.97 - 21.70) 2004 Modelled IHME
15.6 (10.30 - 22.40) 2003 Modelled IHME
16.1 (10.70 - 23.10) 2002 Modelled IHME
16.6 (11 - 23.50) 2001 Modelled IHME
17.1 (11.30 - 24) 2000 Modelled IHME
17.3 (11.50 - 24.40) 1999 Modelled IHME
17.5 (11.60 - 24.70) 1998 Modelled IHME
17.7 (11.90 - 24.80) 1997 Modelled IHME
18 (12.10 - 24.80) 1996 Modelled IHME
18.3 (12.50 - 25.20) 1995 Modelled IHME
19 (13.10 - 26) 1994 Modelled IHME
19.8 (14 - 26.70) 1993 Modelled IHME
20.4 (14.60 - 27.10) 1992 Modelled IHME
21.1 (15.40 - 27.80) 1991 Modelled IHME
21.8 (16.10 - 28.40) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
16 (10 - 24) 2019 Modelled IHME
16 (10 - 24) 2018 Modelled IHME
16 (10 - 23) 2017 Modelled IHME
16 (10 - 24) 2016 Modelled IHME
16 (10 - 23) 2015 Modelled IHME
15 (10 - 23) 2014 Modelled IHME
15 (10 - 23) 2013 Modelled IHME
15 (10 - 22) 2012 Modelled IHME
15 (9 - 22) 2011 Modelled IHME
15 (9 - 21) 2010 Modelled IHME
14 (9 - 21) 2009 Modelled IHME
14 (9 - 21) 2008 Modelled IHME
14 (9 - 20) 2007 Modelled IHME
14 (9 - 20) 2006 Modelled IHME
14 (9 - 20) 2005 Modelled IHME
14 (9 - 20) 2004 Modelled IHME
14 (10 - 21) 2003 Modelled IHME
15 (10 - 21) 2002 Modelled IHME
15 (10 - 21) 2001 Modelled IHME
15 (10 - 21) 2000 Modelled IHME
15 (10 - 21) 1999 Modelled IHME
15 (10 - 21) 1998 Modelled IHME
15 (10 - 20) 1997 Modelled IHME
15 (10 - 20) 1996 Modelled IHME
15 (10 - 20) 1995 Modelled IHME
15 (10 - 20) 1994 Modelled IHME
15 (11 - 21) 1993 Modelled IHME
16 (11 - 21) 1992 Modelled IHME
16 (12 - 21) 1991 Modelled IHME
16 (12 - 21) 1990 Modelled IHME
8 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
57 (48 - 65) 2019 Modelled IHME
57 (48 - 66) 2018 Modelled IHME
57 (48 - 66) 2017 Modelled IHME
57 (48 - 66) 2016 Modelled IHME
57 (48 - 66) 2015 Modelled IHME
57 (48 - 66) 2014 Modelled IHME
57 (48 - 66) 2013 Modelled IHME
57 (48 - 66) 2012 Modelled IHME
57 (48 - 65) 2011 Modelled IHME
57 (49 - 65) 2010 Modelled IHME
57 (49 - 65) 2009 Modelled IHME
57 (49 - 65) 2008 Modelled IHME
57 (49 - 66) 2007 Modelled IHME
57 (49 - 66) 2006 Modelled IHME
57 (49 - 66) 2005 Modelled IHME
58 (50 - 66) 2004 Modelled IHME
58 (50 - 66) 2003 Modelled IHME
58 (50 - 66) 2002 Modelled IHME
58 (50 - 66) 2001 Modelled IHME
58 (50 - 66) 2000 Modelled IHME
58 (50 - 66) 1999 Modelled IHME
58 (50 - 67) 1998 Modelled IHME
58 (50 - 67) 1997 Modelled IHME
58 (50 - 67) 1996 Modelled IHME
58 (50 - 67) 1995 Modelled IHME
58 (50 - 68) 1994 Modelled IHME
58 (50 - 68) 1993 Modelled IHME
59 (50 - 68) 1992 Modelled IHME
59 (50 - 68) 1991 Modelled IHME
59 (50 - 68) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
89 2018 Survey/reported WHO/UNICEF
89 2017 Survey/reported WHO/UNICEF
79 2016 Survey/reported WHO/UNICEF
75 2015 Survey/reported WHO/UNICEF
66 2014 Survey/reported WHO/UNICEF
84 2013 Survey/reported WHO/UNICEF
82 2012 Survey/reported WHO/UNICEF
66 2011 Survey/reported WHO/UNICEF
63 2010 Survey/reported WHO/UNICEF
52 2009 Survey/reported WHO/UNICEF
59 2008 Survey/reported WHO/UNICEF
58 2007 Survey/reported WHO/UNICEF
68 2006 Survey/reported WHO/UNICEF
70 2005 Survey/reported WHO/UNICEF
72 2004 Survey/reported WHO/UNICEF
74 2003 Survey/reported WHO/UNICEF
76 2002 Survey/reported WHO/UNICEF
78 2001 Survey/reported WHO/UNICEF
80 2000 Survey/reported WHO/UNICEF
99 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
95 2018 Survey/reported WHO/UNICEF
90 2017 Survey/reported WHO/UNICEF
81 2016 Survey/reported WHO/UNICEF
82 2015 Survey/reported WHO/UNICEF
75 2014 Survey/reported WHO/UNICEF
95 2013 Survey/reported WHO/UNICEF
94 2012 Survey/reported WHO/UNICEF
95 2011 Survey/reported WHO/UNICEF
91 2010 Survey/reported WHO/UNICEF
86 2009 Survey/reported WHO/UNICEF
83 2008 Survey/reported WHO/UNICEF
96 2007 Survey/reported WHO/UNICEF
88 2006 Survey/reported WHO/UNICEF
50 2005 Survey/reported WHO/UNICEF
67 2004 Survey/reported WHO/UNICEF
73 2003 Survey/reported WHO/UNICEF
79 2002 Survey/reported WHO/UNICEF
85 2001 Survey/reported WHO/UNICEF
90 2000 Survey/reported WHO/UNICEF
82 1999 Survey/reported WHO/UNICEF
89 1998 Survey/reported WHO/UNICEF
97 1997 Survey/reported WHO/UNICEF
66 1996 Survey/reported WHO/UNICEF
36 1995 Survey/reported WHO/UNICEF
36 1994 Survey/reported WHO/UNICEF
8 1993 Survey/reported WHO/UNICEF
6 1992 Survey/reported WHO/UNICEF
7 1991 Survey/reported WHO/UNICEF
73 1990 Survey/reported WHO/UNICEF
94 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Year of birth dose introduction
Year of HBV elimination goal
1998
Eligible for HBV generic medicines
Yes
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.38 (1.10 - 1.73) 2019 Modelled IHME
1.39 (1.10 - 1.72) 2018 Modelled IHME
1.39 (1.09 - 1.73) 2017 Modelled IHME
1.38 (1.10 - 1.71) 2016 Modelled IHME
1.37 (1.12 - 1.71) 2015 Modelled IHME
1.37 (1.12 - 1.69) 2014 Modelled IHME
1.37 (1.12 - 1.70) 2013 Modelled IHME
1.37 (1.11 - 1.70) 2012 Modelled IHME
1.37 (1.10 - 1.69) 2011 Modelled IHME
1.36 (1.09 - 1.69) 2010 Modelled IHME
1.36 (1.08 - 1.68) 2009 Modelled IHME
1.35 (1.08 - 1.67) 2008 Modelled IHME
1.33 (1.07 - 1.65) 2007 Modelled IHME
1.32 (1.06 - 1.62) 2006 Modelled IHME
1.31 (1.04 - 1.62) 2005 Modelled IHME
1.3 (1.04 - 1.61) 2004 Modelled IHME
1.29 (1.03 - 1.60) 2003 Modelled IHME
1.29 (1.03 - 1.58) 2002 Modelled IHME
1.28 (1.02 - 1.56) 2001 Modelled IHME
1.28 (1.02 - 1.57) 2000 Modelled IHME
1.28 (1.03 - 1.57) 1999 Modelled IHME
1.29 (1.04 - 1.57) 1998 Modelled IHME
1.3 (1.04 - 1.58) 1997 Modelled IHME
1.31 (1.05 - 1.60) 1996 Modelled IHME
1.32 (1.04 - 1.62) 1995 Modelled IHME
1.32 (1.05 - 1.62) 1994 Modelled IHME
1.33 (1.05 - 1.63) 1993 Modelled IHME
1.33 (1.05 - 1.64) 1992 Modelled IHME
1.34 (1.06 - 1.65) 1991 Modelled IHME
1.34 (1.06 - 1.66) 1990 Modelled IHME
Showing out of
Show more

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
995 (785 - 1,233) 1990 Modelled IHME
1,008 (796 - 1,242) 1991 Modelled IHME
1,020 (807 - 1,252) 1992 Modelled IHME
1,030 (817 - 1,266) 1993 Modelled IHME
1,039 (823 - 1,278) 1994 Modelled IHME
1,049 (829 - 1,289) 1995 Modelled IHME
1,060 (848 - 1,299) 1996 Modelled IHME
1,070 (858 - 1,303) 1997 Modelled IHME
1,082 (870 - 1,320) 1998 Modelled IHME
1,096 (880 - 1,341) 1999 Modelled IHME
1,114 (888 - 1,367) 2000 Modelled IHME
1,137 (905 - 1,387) 2001 Modelled IHME
1,164 (931 - 1,429) 2002 Modelled IHME
1,194 (950 - 1,473) 2003 Modelled IHME
1,225 (976 - 1,511) 2004 Modelled IHME
1,258 (996 - 1,554) 2005 Modelled IHME
1,294 (1,035 - 1,591) 2006 Modelled IHME
1,332 (1,069 - 1,644) 2007 Modelled IHME
1,371 (1,098 - 1,698) 2008 Modelled IHME
1,407 (1,123 - 1,741) 2009 Modelled IHME
1,438 (1,146 - 1,781) 2010 Modelled IHME
1,463 (1,180 - 1,814) 2011 Modelled IHME
1,485 (1,206 - 1,843) 2012 Modelled IHME
1,506 (1,233 - 1,867) 2013 Modelled IHME
1,527 (1,250 - 1,887) 2014 Modelled IHME
1,549 (1,259 - 1,927) 2015 Modelled IHME
1,579 (1,262 - 1,956) 2016 Modelled IHME
1,608 (1,259 - 2,000) 2017 Modelled IHME
1,627 (1,284 - 2,019) 2018 Modelled IHME
1,639 (1,303 - 2,053) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.07 (3.84 - 11.60) 2019 Modelled IHME
7.06 (3.86 - 11.50) 2018 Modelled IHME
7.05 (3.90 - 11.40) 2017 Modelled IHME
6.97 (3.83 - 11.20) 2016 Modelled IHME
6.92 (3.78 - 11) 2015 Modelled IHME
6.96 (3.80 - 11) 2014 Modelled IHME
7.03 (3.86 - 11.20) 2013 Modelled IHME
7.09 (3.88 - 11.30) 2012 Modelled IHME
7.12 (3.96 - 11.20) 2011 Modelled IHME
7.15 (3.99 - 11.30) 2010 Modelled IHME
7.12 (4.01 - 11.20) 2009 Modelled IHME
7.02 (3.96 - 11) 2008 Modelled IHME
6.9 (3.90 - 10.80) 2007 Modelled IHME
6.81 (3.83 - 10.60) 2006 Modelled IHME
6.77 (3.83 - 10.60) 2005 Modelled IHME
6.87 (3.93 - 10.70) 2004 Modelled IHME
6.98 (3.98 - 10.80) 2003 Modelled IHME
7.08 (4.05 - 10.90) 2002 Modelled IHME
7.21 (4.12 - 11.20) 2001 Modelled IHME
7.38 (4.25 - 11.50) 2000 Modelled IHME
7.53 (4.33 - 11.60) 1999 Modelled IHME
7.63 (4.41 - 11.80) 1998 Modelled IHME
7.73 (4.47 - 11.80) 1997 Modelled IHME
7.8 (4.47 - 11.90) 1996 Modelled IHME
7.91 (4.57 - 12.10) 1995 Modelled IHME
8.11 (4.72 - 12.30) 1994 Modelled IHME
8.34 (4.85 - 12.60) 1993 Modelled IHME
8.46 (4.99 - 12.60) 1992 Modelled IHME
8.56 (5.12 - 12.80) 1991 Modelled IHME
8.59 (5.16 - 12.90) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
8 (5 - 14) 2019 Modelled IHME
8 (5 - 13) 2018 Modelled IHME
8 (5 - 13) 2017 Modelled IHME
8 (4 - 13) 2016 Modelled IHME
8 (4 - 12) 2015 Modelled IHME
8 (4 - 12) 2014 Modelled IHME
8 (4 - 12) 2013 Modelled IHME
8 (4 - 12) 2012 Modelled IHME
8 (4 - 12) 2011 Modelled IHME
8 (4 - 12) 2010 Modelled IHME
7 (4 - 12) 2009 Modelled IHME
7 (4 - 11) 2008 Modelled IHME
7 (4 - 11) 2007 Modelled IHME
7 (4 - 10) 2006 Modelled IHME
7 (4 - 10) 2005 Modelled IHME
6 (4 - 10) 2004 Modelled IHME
6 (4 - 10) 2003 Modelled IHME
6 (4 - 10) 2002 Modelled IHME
6 (4 - 10) 2001 Modelled IHME
6 (4 - 10) 2000 Modelled IHME
6 (4 - 10) 1999 Modelled IHME
6 (4 - 10) 1998 Modelled IHME
6 (4 - 10) 1997 Modelled IHME
6 (4 - 10) 1996 Modelled IHME
6 (4 - 10) 1995 Modelled IHME
6 (4 - 10) 1994 Modelled IHME
6 (4 - 10) 1993 Modelled IHME
6 (4 - 10) 1992 Modelled IHME
6 (4 - 10) 1991 Modelled IHME
6 (4 - 10) 1990 Modelled IHME
1 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
19 (13 - 27) 2019 Modelled IHME
19 (13 - 27) 2018 Modelled IHME
19 (13 - 27) 2017 Modelled IHME
19 (13 - 26) 2016 Modelled IHME
19 (13 - 26) 2015 Modelled IHME
19 (13 - 26) 2014 Modelled IHME
19 (13 - 26) 2013 Modelled IHME
19 (13 - 26) 2012 Modelled IHME
19 (13 - 26) 2011 Modelled IHME
19 (13 - 26) 2010 Modelled IHME
19 (13 - 26) 2009 Modelled IHME
19 (13 - 25) 2008 Modelled IHME
19 (13 - 25) 2007 Modelled IHME
19 (13 - 25) 2006 Modelled IHME
19 (13 - 25) 2005 Modelled IHME
19 (13 - 25) 2004 Modelled IHME
18 (13 - 25) 2003 Modelled IHME
18 (13 - 25) 2002 Modelled IHME
18 (13 - 25) 2001 Modelled IHME
18 (13 - 25) 2000 Modelled IHME
19 (13 - 25) 1999 Modelled IHME
19 (13 - 25) 1998 Modelled IHME
19 (13 - 25) 1997 Modelled IHME
19 (13 - 25) 1996 Modelled IHME
19 (13 - 26) 1995 Modelled IHME
19 (13 - 26) 1994 Modelled IHME
19 (13 - 26) 1993 Modelled IHME
19 (13 - 26) 1992 Modelled IHME
19 (13 - 26) 1991 Modelled IHME
19 (13 - 26) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Year of birth dose introduction
Year of HBV elimination goal
1998
Eligible for HBV generic medicines
Yes
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Overview

HBV elimination goal
Year of goal
1998
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
16
2019
(10 - 24)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
8
2019
(5 - 14)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
99 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Yes
Eligible for HCV generic medicines

Partners